{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:19:23Z","timestamp":1784819963271,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jsat.2010.04.001","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T11:38:37Z","timestamp":1276169917000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Factors associated with complicated buprenorphine inductions"],"prefix":"10.1016","volume":"39","author":[{"given":"Susan D.","family":"Whitley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Sohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary V.","family":"Kunins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Giovanniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Sacajiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2010.04.001_bib1","series-title":"Diagnostic and statistical manual of mental disorders fourth edition, text revision","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.jsat.2010.04.001_bib2","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment improvement protocol (TIP) series 40","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"10.1016\/j.jsat.2010.04.001_bib3","first-page":"248","article-title":"Buprenorphine treatment in an urban community health center: What to expect","volume":"40","author":"Cunningham","year":"2008","journal-title":"Family Medicine"},{"key":"10.1016\/j.jsat.2010.04.001_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ADM.0b013e3180473c11","article-title":"The first three years of buprenorphine in the United States: Experience to date and future directions","volume":"1","author":"Fiellin","year":"2007","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2010.04.001_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1300\/J069v25n04_09","article-title":"Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence","volume":"25","author":"Kissin","year":"2006","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2010.04.001_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.04.001_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care","volume":"24","author":"Lee","year":"2009","journal-title":"Journal of General Internal Medicine"},{"issue":"6 Suppl. 2","key":"10.1016\/j.jsat.2010.04.001_bib8","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00004714-199912002-00002","article-title":"Effectiveness and safety of benzodiazepines","volume":"19","author":"Moller","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2010.04.001_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jsat.2008.06.006","article-title":"Factors affecting willingness to provide buprenorphine treatment","volume":"36","author":"Netherland","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.04.001_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O'Connor","year":"1998","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.jsat.2010.04.001_bib11","author":"Olson"},{"key":"10.1016\/j.jsat.2010.04.001_bib12","author":"PCSSmentor.org"},{"key":"10.1016\/j.jsat.2010.04.001_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1046\/j.1360-0443.1998.93913859.x","article-title":"Six deaths linked to concomitant use of buprenorphine and benzodiazepines","volume":"93","author":"Reynaud","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2010.04.001_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2007.04.006","article-title":"Sublingual buprenorphine\/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone","volume":"90","author":"Rosado","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2010.04.001_bib15","series-title":"Results from the 2007 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2008"},{"key":"10.1016\/j.jsat.2010.04.001_bib16","series-title":"Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights\u20142007.","author":"Substance Abuse and Mental Health Services Administration","year":"2009"},{"key":"10.1016\/j.jsat.2010.04.001_bib17","article-title":"Home- vs. office-based buprenorphine inductions for opioid dependent patients","author":"Sohler","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2010.04.001_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology\/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"key":"10.1016\/j.jsat.2010.04.001_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0022-3565(25)24449-4","article-title":"Buprenorphine effects in methadone-maintained volunteers: Effects at two hours after methadone","volume":"272","author":"Strain","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.jsat.2010.04.001_bib20","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2010.04.001_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547210000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:34:07Z","timestamp":1760038447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547210000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0740547210000772"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2010.04.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with complicated buprenorphine inductions","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2010.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}